.show-script { display: block; } .hide-script { display: none; }

Enable Javascript to enjoy full feature!

1 week ago

Eli Lilly (LLY) Finalizes $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline

Eli Lilly (LLY) completed its $2.8B AtaiBeckley acquisition on Sept 11, 2026. Shareholders received $6.75/share plus CVRs worth up to $2.50 more.

The post Eli Lilly (LLY) Finalizes $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline appeared first on Blockonomi.

Source: Blockonomi →

Related News